Biolife Solutions (BLFS) EBT Margin (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of EBT Margin data on file, last reported at 4.54% in Q1 2026.

• EBT Margin for Q1 2026 came in at 4.54%, up 325.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.42% (down 358.0% YoY), and the FY2025 annual result was 12.56%, down 74.0% from the prior year.
• EBT Margin fell to 4.54% in Q1 2026 per BLFS's latest filing, from 17.9% in the prior quarter.
• Over five years, EBT Margin peaked at 17.9% in Q4 2025 and troughed at 219.83% in Q4 2022.
• A 5-year average of 46.23% and a median of 22.14% in 2022 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 17404 bps in 2022, then jumped 17016 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 219.83% in 2022, then jumped by 43 bps to 126.02% in 2023, then surged by 102 bps to 3.1% in 2024, then soared by 477 bps to 17.9% in 2025, then sank by 75 bps to 4.54% in 2026.
• Business Quant data shows BLFS's EBT Margin at 4.54% in Q1 2026, 17.9% in Q4 2025, and 2.5% in Q3 2025.